| Outcome | Probability | Yes Bid | Yes Ask | 24h Change | Volume | |
|---|---|---|---|---|---|---|
| Hashiras | 0% | 0¢ | 0¢ | — | $0 | Trade → |
| MINLATE | 0% | 0¢ | 0¢ | — | $0 | Trade → |
This market asks which team will win Map 2 of the CCT Europe Series #19 match between Hashiras and MINLATE; it matters because map-level results determine series progression and are a common focus for short-term trading and hedging.
CCT Europe Series is a regional Counter‑Strike tournament series; a Map 2 market sits inside a best‑of series context where map picks, vetoes, and the Map 1 result shape expectations. Hashiras and MINLATE bring distinct map pools and recent form into the matchup, so Map 2 can be pivotal for momentum and series outcome.
Market prices represent the collective market view of which side will win Map 2 and react to new information (lineups, map vetoes, delays); they summarize consensus expectations but do not guarantee the outcome.
This market settles on the official winner of Map 2 as recorded by the tournament organizer and platform; the officially reported map winner (including any overtime result) determines settlement.
The market close is listed as TBD; typically map‑level markets close shortly before the scheduled start time for that map, so monitor the platform for an exact close time tied to the map start.
Map 1 outcome affects momentum, veto strategy for Map 2, and perceived pressure on each side; traders often reprice the Map 2 market immediately after Map 1 based on visible adjustments and tactical changes.
Roster announcements do not change settlement rules but are material information for traders: unexpected substitutions or stand‑ins can alter team chemistry and map performance, prompting rapid market repricing.
Settlement follows the tournament organizer's official outcome and the platform's event rules: postponement or cancellation may pause or void the market per platform policy, while venue/server changes are relevant to competitive conditions but do not by themselves change settlement criteria.